Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2026-05-05 @ 5:10 AM
Study NCT ID:
NCT02188550
Status:
UNKNOWN
Last Update Posted:
2015-05-19
First Post:
2014-05-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
Sponsor:
Sinai Hospital of Baltimore
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CRAD001CUS242T
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None